[company_age]6.0[/company_age][employees]51-200 employees[/employees][funding]Series unknown[/funding][description]MediCrops® AG, a Swiss-based pioneer in the medical cannabis field, was established in 2018. They are dedicated to improving patient care through advanced therapeutic solutions. Their mission is to significantly improve the quality of life for patients by developing, researching, and distributing high-quality cannabis products. Their comprehensive product portfolio aims to address a wide range of health conditions where cannabis-based medicines can play a crucial role. MediCrops works closely with medical professionals and patients to ensure the best possible care. Through their innovative telemedicine platform, they enable access to qualified medical advice and therapy support from the comfort of home. Educating doctors and healthcare professionals on the use of medical cannabis is another focus of their work. Their goal is to expand knowledge and promote the acceptance of cannabis-based therapies in healthcare. As a leader in the industry, they are committed to quality, safety, and continuous improvement of their products and services. MediCrops AG stands for innovation and dedication in the service of health, with the clear aim of expanding treatment options for patients worldwide. What sets MediCrops apart is their focus on telemedicine and patient education, making them a unique player in the medical cannabis field.[/description][ps]High-quality cannabis products, telemedicine platform, medical advice and therapy support, education on medical cannabis.[/ps]